AEON Biopharma, Inc.
AEON
$0.75
-$0.07-7.98%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -28.39% | 4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.21% | 9.42% | |||
| Operating Income | 32.21% | -9.42% | |||
| Income Before Tax | 31.68% | -173.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.68% | -173.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.68% | -173.03% | |||
| EBIT | 32.21% | -9.42% | |||
| EBITDA | 32.33% | -9.44% | |||
| EPS Basic | 34.88% | -126.24% | |||
| Normalized Basic EPS | 38.12% | -123.69% | |||
| EPS Diluted | 35.00% | -126.29% | |||
| Normalized Diluted EPS | 38.12% | -123.69% | |||
| Average Basic Shares Outstanding | 4.91% | 178.32% | |||
| Average Diluted Shares Outstanding | 4.91% | 178.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||